瘤中介素-1β前体的一个月光功能通过RACK1-介导的动蛋白重塑促进转移
Quanzhu Chen1,2,3,4,5, Pan Wu1,2,3,4, Jing Cai6
1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Nature communications
|November 19, 2025
概括
互乐金-1β的非活性前体 (Pro-IL-1β) 通过稳定RACK1.1,驱动头癌转移. 一种天然化合物Q3MG降解了Pro-IL-1β,抑制了癌症的传播.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 干白素-1β (IL-1β) 是一种促炎性细胞因子,与癌症进展有关.
- 前体形式,Pro-IL-1β,传统上被认为是生物不活跃的.
- 头部和部状细胞癌 (HNSCC) 是一个重要的全球健康问题,转移率高.
研究的目的:
- 调查Pro-IL-1β在HNSCC进展中的作用.
- 阐明Pro-IL-1β介导的瘤入侵和转移背后的分子机制.
- 在转移性癌症中确定针对Pro-IL-1β的潜在治疗策略.
主要方法:
- 在HNSCC细胞中分析Pro-IL-1β表达.
- 研究Pro-IL-1β,RACK1和UBET2之间的相互作用.
- 使用RACK1的基因抑制和体外/体内试验.
- 评估自然化合物Q3MG的治疗潜力.
主要成果:
- 在HNSCC细胞中增加的Pro-IL-1β表达,由超强增强剂活性驱动.
- 细胞内部的Pro-IL-1β促进了独立于IL-1β处理的入侵和转移.
- 亲IL-1β通过抑制其无处不在,激活RhoA信号和促进细胞骨重塑来稳定RACK1.
- RACK1的抑制会取消Pro-IL-1β诱导的转移,在HNSCC标本中具有临床相关性.
- Q3MG直接与Pro-IL-1β结合,诱导其降解并抑制转移.
结论:
- 在促进HNSCC转移方面,Pro-IL-1β具有非正规的功能.
- 亲IL-1β-RACK1-RhoA信号轴对于瘤入侵和细胞骨动态至关重要.
- Q3MG证明了作为一种抑制Pro-IL-1β驱动的转移性进展的治疗潜力.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Intracellular Signaling Affects Focal Adhesions
3.4K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.4K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K


